Table 1 Patient demographics and relevant baseline characteristics
Fingolimod 0.5 mg (N = 3951) | |
|---|---|
Age groups in years, n (%) | |
18–30 | 880 (22.3) |
> 30–40 | 1222 (30.9) |
> 40–55 | 1622 (41.1) |
> 55–65 | 208 (5.3) |
> 65 | 18 (0.5) |
Sex | |
Female, n (%) | 2779 (70.3) |
Duration of MS since first symptoms in years, mean ± SD | 10.0 ± 7.6 |
Number of relapses in previous year, mean ± SD | 1.6 ± 1.2 |
EDSS, mean ± SD | 2.8 ± 1.6 |
DMT treatment within the last 6 months, n (%) | |
No | 827 (20.9) |
Yes | 3124 (79.1) |